Clinical Trial Update: Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs [NA]

View source ↗

Summary

A completed clinical trial evaluating a smartphone-based aDOT treatment approach with fixed-dose elbasvir and grazoprevir in people who inject drugs for Hepatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Elbasvir/Grazoprevir (elbasvir/grazoprevir)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Hepatitis C, Medication Adherence | NA | Status: COMPLETED | Results posted: 2021-09-14